Searchable abstracts of presentations at key conferences in endocrinology

ea0056p858 | Pituitary - Clinical | ECE2018

Consensus on the management of acromegaly in Spain

Bernabeu Ignacio , Camara Rosa , Marazuela Monica , Domingo Manel Puig

Objective: To find consensus on issues that may raise clinical doubts in the management of patients with acromegaly in Spain.Methods: Nominal group and Delphi methodology was followed. Four experts on acromegaly were selected, who defined important clinical questions in the management of acromegaly. A set recommendations were proposed to solve these questions. Subsequently, a group of 30 additional endocrinologits from all over Spain was selected accordi...

ea0037ep1052 | Thyroid (non-cancer) | ECE2015

Percutaneous ethanol injection as a first line treatment of cystic thyroid nodules: experience after its introduction in a university hospital

Reverter Jordi L , Alonso Nuria , Ordonez Isabel , Cuadrado Maribel , Cano Lucia , Mauricio Didac , Domingo Manel Puig

Objectives: To evaluate the efficacy, safety and patient’s pain perception of percutaneous ethanol injection treatment (PEIT) as an alternative to surgery in symptomatic thyroid cysts.Patients and methods: Thirty consecutive patients (mean age: 46±10 years; 82% women) with symptomatic thyroid cysts relapsed after drainage were included. In all cases, cytology prior to treatment, maximum cyst diameter and volume were determined. PEIT was conduct...

ea0056gp139 | Neuroendocrinology | ECE2018

Why don’t corticotroph tumours always produce Cushing disease?

Garcia-Martinez Araceli , Cano David , Gil Joan , Fajardo Carmen , Camara Rosa , Lamas Cristina , Soto Alfonso , Puig Manel , Webb Susan M

Introduction: Silent corticotroph tumours (SCT) are a pituitary tumours (PT) subtype of corticotroph lineage that do not clinically express Cushing disease. Inmunohistochemical (IHC) studies reveal no differences between SCT and functioning corticotroph tumours with Cushing Syndrome (FCT). However, the silencing mechanisms of this type of tumours are not fully understood.Aim: In an important series of SCT, to sequence the POMC gene and quantify ...

ea0014p219 | (1) | ECE2007

Prevalence of metabolic syndrome in old men and its relation to ghrelin

Alfaro Sergio Rueda , Serra-Prat Mateu , Fernández Cristián Fernández , Palomera Elisabet , Casamitjana Roser , Domingo Manel Puig

Aim: To study the prevalence of metabolic syndrome (MS) and its relation with ghrelin in old men.Material and methods: Prospective-population based study (2002–2005) in which 153 independently living men older than 70 y were included. Comorbidities, physical exam, BMI, blood pressure were recorded and blood sample taken for biochemical and hormonal determinations. Metabolic syndrome was defined using IDF criteria.Results: MS w...

ea0070aep953 | Thyroid | ECE2020

Diagnostic patterns of relapsed differentiated thyroid cancer (DTC) and the efficacy of rescue therapies (ERUDIT Study)

Sambo Marcel , Navarro Elena , Aller Javier , Guadalix Sonsoles , Zafón Carlos , González Cristina , Santamaría Javier , González Marcelino , Puig Manel , Galofré Juan C. , Argüelles Iñaki , Vallejo Juan A. , Pubul Virginia , Santos Rita , Llanos Marta , Crespo Guillermo , Segura Ángel , Navarro Miguel , Gajate Pablo , Valdivia Javier , López Carlos , Castelo Beatriz , Villanueva María J. , Araujo Fábia , Orcajo Lorenzo , Rodríguez-Villanueva Julio

Introduction: Advanced differentiated thyroid carcinoma (aDTC) – herein defined as locally unresectable or metastatic disease – is one of the most common late-stage endocrine neoplasias. However, available data about its natural history is limited. ERUDIT is a multicenter, observational, retrospective study of patients diagnosed with aDTC in Spain and Portugal. The study describes its natural history from the initial diagnosis until the advanced stages of disease, ...